Bertrand Tombal is Chairman of the Division of Urology and Professor of Urology at the Université Catholique de Louvain (UCL), Cliniques universitaires Saint-Luc, in Brussels, Belgium. Prof. Tombal obtained his MD, in 1990, and his PhD, in 2003, both from the Université Catholique de Louvain. His PhD research focused on the mechanisms involved in apoptosis of prostate cancer cells and the modulation of apoptosis by growth factors. Prof. Tombal completed part of his basic sciences training at Johns Hopkins University in Baltimore, MD, USA.
Prof. Tombal’s primary clinical interest centres on the treatment of advanced stages of prostate cancer, particularly hormonal treatment and the development of new biological agents. He is heading the urooncology division at the Université catholique de Louvain where he is coordinating several trials in this research area.
Prof. Tombal is a member of the Royal Academy of Medicine of Belgium and is the current President of the European Organisation for Research and Treatment of Cancer (EORTC). He has been the recipient of various awards for his research in the field of urology, including the European Association of Urology (EAU) thesis award, which he received in 2003.
Prof. Tombal has published many articles, books, and book chapters, and has presented at numerous national and international conferences.
EM-15206 - Date of preparation: July 2019